Hybrid Bivalent Ligands with Opiate and Enkephalin Pharmacophores

P. S. Portoehese, D. L. Larson, G. Ronsisvalle, P. W. Schiller, T. M.D. Nguyen, C. Lemieux, A. E. Takemori

Research output: Contribution to journalArticlepeer-review

20 Scopus citations


Bivalent ligands consisting of oxymorphamine and [d-G1u2] enkephalin pharmacophores linked through a spacer attached to the 6-amino group of the former and D-Glu of the latter were synthesized in an effort to investigate the possible coexistence of and recognition sites in the same opioid receptor complex. Of the two bivalent ligands (1,2) synthesized, only 1 had substantially greater antinociceptive potency in mice than its monovalent analogues (la, lb). Testing of 1, la, and lb in the guinea pig ileum preparation (GPI) revealed a potency profile similar to that found in vivo, whereas no correlation was observed in the mouse vas deferens (MVD). Binding data indicated the same rank-order affinities at receptors as the opioid activities in the GPI and in mice. However, binding exhibited no relationship with activity. These results are consistent with the simultaneous occupation of and by a single bivalent ligand 1, but they are also in harmony with the interaction of 1 with an opioid receptor and an accessory binding site.

Original languageEnglish (US)
Pages (from-to)1991-1994
Number of pages4
JournalJournal of medicinal chemistry
Issue number11
StatePublished - Nov 1 1987


Dive into the research topics of 'Hybrid Bivalent Ligands with Opiate and Enkephalin Pharmacophores'. Together they form a unique fingerprint.

Cite this